-
2
-
-
29244482288
-
Definition of the metabolic syndrome: Current proposals and controversies
-
Reisin E, Alpert MA. Definition of the metabolic syndrome: current proposals and controversies. American J the Medical Sciences 2005; 330: 269-72.
-
(2005)
American J the Medical Sciences
, vol.330
, pp. 269-272
-
-
Reisin, E.1
Alpert, M.A.2
-
3
-
-
0000939795
-
Studien uber das Hypertonie-Hyperglyka 'mie- Hyperurika' miesyndrom
-
Kylin E. Studien uber das Hypertonie-Hyperglyka 'mie- Hyperurika' miesyndrom. Zentralbl Inn Med 1923; 44: 105-27.
-
(1923)
Zentralbl Inn Med
, vol.44
, pp. 105-127
-
-
Kylin, E.1
-
4
-
-
0001217241
-
Sexual differentiation, A factor affecting the forms of obesity
-
Vague J. Sexual differentiation, A factor affecting the forms of obesity. Presse Med 1947; 30: 339-40.
-
(1947)
Presse Med
, vol.30
, pp. 339-340
-
-
Vague, J.1
-
5
-
-
0023816690
-
Role of insulin in regulation of lipoprotein metabolism in diabetes
-
Reaven GM, Chen YD. Role of insulin in regulation of lipoprotein metabolism in diabetes. Diabetes/Metabolism Reviews 1988; 4: 639-52.
-
(1988)
Diabetes/Metabolism Reviews
, vol.4
, pp. 639-652
-
-
Reaven, G.M.1
Chen, Y.D.2
-
6
-
-
0035856920
-
Global and societal implications of the diabetes epidemic
-
Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-7.
-
(2001)
Nature
, vol.414
, pp. 782-787
-
-
Zimmet, P.1
Alberti, K.G.2
Shaw, J.3
-
10
-
-
10044279220
-
Prevalence of atherosclerotic vascular disease among subjects with the metabolic syndrome with or without diabetes mellitus: The METSGREECE Multicentre Study
-
Athyros VG, Mikhailidis DP, Papageorgiou AA, et al. Prevalence of atherosclerotic vascular disease among subjects with the metabolic syndrome with or without diabetes mellitus: the METSGREECE Multicentre Study. Current Medical Research and Opinion 2004; 20: 1691-1701.
-
(2004)
Current Medical Research and Opinion
, vol.20
, pp. 1691-1701
-
-
Athyros, V.G.1
Mikhailidis, D.P.2
Papageorgiou, A.A.3
-
12
-
-
0344946139
-
Recommendations for special populations: Diabetes mellitus and the metabolic syndrome
-
Sowers JR. Recommendations for special populations: diabetes mellitus and the metabolic syndrome. American J Hypertension 2003; 16: 41S-45S.
-
(2003)
American J Hypertension
, vol.16
-
-
Sowers, J.R.1
-
14
-
-
0037031088
-
Adiponectin and development of type 2 diabetes in the Pima Indian population
-
Lindsay RS, Funahashi T, Hanson RL, et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002; 360: 57-8.
-
(2002)
Lancet
, vol.360
, pp. 57-58
-
-
Lindsay, R.S.1
Funahashi, T.2
Hanson, R.L.3
-
15
-
-
77954921980
-
Markers of oxidative damage are not elevated in otherwise healthy individuals with the metabolic syndrome
-
Seet RC, Lee CY, Lim EC, et al. Markers of oxidative damage are not elevated in otherwise healthy individuals with the metabolic syndrome. Diabetes Care 2010; 33: 1140-2.
-
(2010)
Diabetes Care
, vol.33
, pp. 1140-1142
-
-
Seet, R.C.1
Lee, C.Y.2
Lim, E.C.3
-
16
-
-
10044263319
-
Adiponectin, obesity, and cardiovascular disease
-
Fasshauer M, Paschke R, Stumvoll M. Adiponectin, obesity, and cardiovascular disease. Biochimie 2004; 86: 779-84.
-
(2004)
Biochimie
, vol.86
, pp. 779-784
-
-
Fasshauer, M.1
Paschke, R.2
Stumvoll, M.3
-
19
-
-
0034891684
-
Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin
-
Yang WS, Lee WJ, Funahashi T, et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clinical Endocrinology & Metabolism 2001; 86: 3815-9.
-
(2001)
J Clinical Endocrinology & Metabolism
, vol.86
, pp. 3815-3819
-
-
Yang, W.S.1
Lee, W.J.2
Funahashi, T.3
-
20
-
-
0037540732
-
Resistin and adiponectin expression in visceral fat of obese rats: Effect of weight loss
-
Milan G, Granzotto M, Scarda A, et al. Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss. Obesity Research 2002; 10: 1095-103.
-
(2002)
Obesity Research
, vol.10
, pp. 1095-1103
-
-
Milan, G.1
Granzotto, M.2
Scarda, A.3
-
21
-
-
9144263120
-
A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity
-
Combs TP, Pajvani UB, Berg AH, et al. A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology 2004; 145: 367-83.
-
(2004)
Endocrinology
, vol.145
, pp. 367-383
-
-
Combs, T.P.1
Pajvani, U.B.2
Berg, A.H.3
-
22
-
-
33744797675
-
Leptin: A promising therapeutic target with pleiotropic action besides body weight regulation
-
Paraskevas KI, Liapis CD, Mikhailidis DP. Leptin: a promising therapeutic target with pleiotropic action besides body weight regulation. Current Drug Targets 2006; 7: 761-71.
-
(2006)
Current Drug Targets
, vol.7
, pp. 761-771
-
-
Paraskevas, K.I.1
Liapis, C.D.2
Mikhailidis, D.P.3
-
23
-
-
17944365228
-
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity
-
Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Natural Medicines 2001; 7: 941-6.
-
(2001)
Natural Medicines
, vol.7
, pp. 941-946
-
-
Yamauchi, T.1
Kamon, J.2
Waki, H.3
-
24
-
-
0000454838
-
Insulin resistance: The fundamental trigger of type 2 diabetes
-
Groop LC. Insulin resistance: the fundamental trigger of type 2 diabetes. Diabetes, Obesity and Metabolism 1999; 1 Suppl 1: S1-7.
-
(1999)
Diabetes, Obesity and Metabolism
, vol.1
, Issue.SUPPL. 1
-
-
Groop, L.C.1
-
25
-
-
0037019586
-
Relationship between obesity, insulin resistance, and coronary heart disease risk
-
Abbasi F, Brown BW, Jr., Lamendola C, McLaughlin T, Reaven GM. Relationship between obesity, insulin resistance, and coronary heart disease risk. J the American College of Cardiology 2002; 40: 937-43.
-
(2002)
J the American College of Cardiology
, vol.40
, pp. 937-943
-
-
Abbasi, F.1
Brown Jr., B.W.2
Lamendola, C.3
McLaughlin, T.4
Reaven, G.M.5
-
26
-
-
33645860825
-
Reactive oxygen species have a causal role in multiple forms of insulin resistance
-
Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006; 440: 944-8.
-
(2006)
Nature
, vol.440
, pp. 944-948
-
-
Houstis, N.1
Rosen, E.D.2
Lander, E.S.3
-
27
-
-
33747855564
-
Dyslipidaemia, hypercoagulability and the metabolic syndrome
-
Kakafika AI, Liberopoulos EN, Karagiannis A, Athyros VG, Mikhailidis DP. Dyslipidaemia, hypercoagulability and the metabolic syndrome. Current Vascular Pharmacology 2006; 4: 175-83.
-
(2006)
Current Vascular Pharmacology
, vol.4
, pp. 175-183
-
-
Kakafika, A.I.1
Liberopoulos, E.N.2
Karagiannis, A.3
Athyros, V.G.4
Mikhailidis, D.P.5
-
28
-
-
33846192751
-
Clinical importance and therapeutic modulation of small dense low-density lipoprotein particles
-
Gazi IF, Tsimihodimos V, Tselepis AD, Elisaf M, Mikhailidis DP. Clinical importance and therapeutic modulation of small dense low-density lipoprotein particles. Expert Opinion on Biological Therapy 2007; 7: 53-72.
-
(2007)
Expert Opinion on Biological Therapy
, vol.7
, pp. 53-72
-
-
Gazi, I.F.1
Tsimihodimos, V.2
Tselepis, A.D.3
Elisaf, M.4
Mikhailidis, D.P.5
-
29
-
-
33846516394
-
Small, dense low-density-lipoproteins and the metabolic syndrome
-
Rizzo M, Berneis K. Small, dense low-density-lipoproteins and the metabolic syndrome. Diabetes/Metabolism Research and Reviews 2007; 23: 14-20.
-
(2007)
Diabetes/Metabolism Research and Reviews
, vol.23
, pp. 14-20
-
-
Rizzo, M.1
Berneis, K.2
-
30
-
-
84910110212
-
The insulin resistance syndrome: Impact on lipoprotein metabolism and atherothrombosis
-
Ginsberg HN, Huang LS. The insulin resistance syndrome: impact on lipoprotein metabolism and atherothrombosis. J Cardiovascular Risk 2000; 7: 325-31.
-
(2000)
J Cardiovascular Risk
, vol.7
, pp. 325-331
-
-
Ginsberg, H.N.1
Huang, L.S.2
-
31
-
-
0037417237
-
Treatment for patients with the metabolic syndrome
-
Ginsberg HN. Treatment for patients with the metabolic syndrome. Amn J Cardiol 2003; 91: 29E-39E.
-
(2003)
Amn J Cardiol
, vol.91
-
-
Ginsberg, H.N.1
-
32
-
-
79954620383
-
Diabetes and antioxidants: Myth or reality?
-
Haidara MA, Yassin HZ, Zakula Z, Mikhailidis DP, Isenovic ER. Diabetes and antioxidants: myth or reality? Current Vascular Pharmacology 2010; 8: 661-72.
-
(2010)
Current Vascular Pharmacology
, vol.8
, pp. 661-672
-
-
Haidara, M.A.1
Yassin, H.Z.2
Zakula, Z.3
Mikhailidis, D.P.4
Isenovic, E.R.5
-
33
-
-
80051725784
-
"European Panel on Low Density Lipoprotein (LDL) Subclasses": A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses
-
Mikhailidis DP, Elisaf M, Rizzo M, et al. "European Panel on Low Density Lipoprotein (LDL) Subclasses": A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses. Current Vascular Pharmacology 2011; 9: 533-71.
-
(2011)
Current Vascular Pharmacology
, vol.9
, pp. 533-571
-
-
Mikhailidis, D.P.1
Elisaf, M.2
Rizzo, M.3
-
34
-
-
80051769525
-
"European Panel on Low Density Lipoprotein (LDL) Subclasses": A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses: Executive Summary
-
Mikhailidis DP, Elisaf M, Rizzo M, et al. "European Panel on Low Density Lipoprotein (LDL) Subclasses": A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses: Executive Summary. Current Vascular Pharmacology 2011; 9: 531-2.
-
(2011)
Current Vascular Pharmacology
, vol.9
, pp. 531-532
-
-
Mikhailidis, D.P.1
Elisaf, M.2
Rizzo, M.3
-
36
-
-
0035254845
-
Enhanced oxidative susceptibility and reduced antioxidant content of metabolic precursors of small, dense low-density lipoproteins
-
Tribble DL, Rizzo M, Chait A, Lewis DM, Blanche PJ, Krauss RM. Enhanced oxidative susceptibility and reduced antioxidant content of metabolic precursors of small, dense low-density lipoproteins. American J Medicine 2001; 110: 103-10.
-
(2001)
American J Medicine
, vol.110
, pp. 103-110
-
-
Tribble, D.L.1
Rizzo, M.2
Chait, A.3
Lewis, D.M.4
Blanche, P.J.5
Krauss, R.M.6
-
37
-
-
34547859254
-
Association of oxidative stress and PON1 with LDL and HDL particle size in middle-aged subjects
-
Vekic J, Kotur-Stevuljevic J, Jelic-Ivanovic Z, et al. Association of oxidative stress and PON1 with LDL and HDL particle size in middle-aged subjects. European J Clinical Investigation 2007; 37: 715-23.
-
(2007)
European J Clinical Investigation
, vol.37
, pp. 715-723
-
-
Vekic, J.1
Kotur-Stevuljevic, J.2
Jelic-Ivanovic, Z.3
-
38
-
-
60749105826
-
High serum uric acid and low-grade inflammation are associated with smaller LDL and HDL particles
-
Vekic J, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V, et al. High serum uric acid and low-grade inflammation are associated with smaller LDL and HDL particles. Atherosclerosis 2009; 203: 236-42.
-
(2009)
Atherosclerosis
, vol.203
, pp. 236-242
-
-
Vekic, J.1
Jelic-Ivanovic, Z.2
Spasojevic-Kalimanovska, V.3
-
39
-
-
0346363234
-
Inflammation meets oxidation: NF-kappaB as a mediator of initial lesion development in atherosclerosis
-
Kutuk O, Basaga H. Inflammation meets oxidation: NF-kappaB as a mediator of initial lesion development in atherosclerosis. Trends in Molecular Medicine 2003; 9: 549-57.
-
(2003)
Trends in Molecular Medicine
, vol.9
, pp. 549-557
-
-
Kutuk, O.1
Basaga, H.2
-
40
-
-
33745140143
-
Concentration and relative distribution of low-density lipoprotein subfractions in patients with metabolic syndrome defined according to the National Cholesterol Education Program criteria
-
Gazi I, Tsimihodimos V, Filippatos T, Bairaktari E, Tselepis AD, Elisaf M. Concentration and relative distribution of low-density lipoprotein subfractions in patients with metabolic syndrome defined according to the National Cholesterol Education Program criteria. Metabolism: Clinical and Experimental 2006; 55: 885-91.
-
(2006)
Metabolism: Clinical and Experimental
, vol.55
, pp. 885-891
-
-
Gazi, I.1
Tsimihodimos, V.2
Filippatos, T.3
Bairaktari, E.4
Tselepis, A.D.5
Elisaf, M.6
-
41
-
-
37249058017
-
Small dense LDL particles and metabolic syndrome in a sample of middle-aged women. Findings from Progetto Atena
-
Gentile M, Panico S, Jossa F, Mattiello A, et al. Small dense LDL particles and metabolic syndrome in a sample of middle-aged women. Findings from Progetto Atena. Clinica Chimica Acta 2008; 388: 179-83.
-
(2008)
Clinica Chimica Acta
, vol.388
, pp. 179-183
-
-
Gentile, M.1
Panico, S.2
Jossa, F.3
Mattiello, A.4
-
42
-
-
35348843962
-
Factors influencing the formation of small dense low-density lipoprotein particles in dependence on the presence of the metabolic syndrome and on the degree of glucose intolerance
-
Julius U, Dittrich M, Pietzsch J. Factors influencing the formation of small dense low-density lipoprotein particles in dependence on the presence of the metabolic syndrome and on the degree of glucose intolerance. International J Clinical Practice 2007; 61: 1798-804.
-
(2007)
International J Clinical Practice
, vol.61
, pp. 1798-1804
-
-
Julius, U.1
Dittrich, M.2
Pietzsch, J.3
-
43
-
-
27444443876
-
Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
-
Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-52.
-
(2005)
Circulation
, vol.112
, pp. 2735-2752
-
-
Grundy, S.M.1
Cleeman, J.I.2
Daniels, S.R.3
-
44
-
-
64349088492
-
Small, dense low-density lipoproteins (LDL) are predictors of cardio - and cerebro-vascular events in subjects with the metabolic syndrome
-
Rizzo M, Pernice V, Frasheri A, et al. Small, dense low-density lipoproteins (LDL) are predictors of cardio- and cerebro-vascular events in subjects with the metabolic syndrome. Clinical Endocrinology 2009; 70: 870-5.
-
(2009)
Clinical Endocrinology
, vol.70
, pp. 870-875
-
-
Rizzo, M.1
Pernice, V.2
Frasheri, A.3
-
45
-
-
0036176783
-
Plasma free fatty acid levels and the risk of ischemic heart disease in men: Prospective results from the Quebec Cardiovascular Study
-
Pirro M, Mauriege P, Tchernof A, et al. Plasma free fatty acid levels and the risk of ischemic heart disease in men: prospective results from the Quebec Cardiovascular Study. Atherosclerosis 2002; 160: 377-84.
-
(2002)
Atherosclerosis
, vol.160
, pp. 377-384
-
-
Pirro, M.1
Mauriege, P.2
Tchernof, A.3
-
46
-
-
0035954846
-
Postprandial dyslipidemia: An atherogenic disorder common in patients with diabetes mellitus
-
Ginsberg HN, Illingworth DR. Postprandial dyslipidemia: an atherogenic disorder common in patients with diabetes mellitus. American J Cardiology 2001; 88: 9H-15H.
-
(2001)
American J Cardiology
, vol.88
-
-
Ginsberg, H.N.1
Illingworth, D.R.2
-
48
-
-
0021367111
-
In vivo stimulation of low-density lipoprotein degradation by insulin
-
Mazzone T, Foster D, Chait A. In vivo stimulation of low-density lipoprotein degradation by insulin. Diabetes 1984; 33: 333-8.
-
(1984)
Diabetes
, vol.33
, pp. 333-338
-
-
Mazzone, T.1
Foster, D.2
Chait, A.3
-
49
-
-
0028858162
-
Acute hyperinsulinemia decreases the hepatic secretion of very-lowdensity lipoprotein apolipoprotein B-100 in NIDDM
-
Cummings MH, Watts GF, Umpleby AM, et al. Acute hyperinsulinemia decreases the hepatic secretion of very-lowdensity lipoprotein apolipoprotein B-100 in NIDDM. Diabetes 1995; 44: 1059-65.
-
(1995)
Diabetes
, vol.44
, pp. 1059-1065
-
-
Cummings, M.H.1
Watts, G.F.2
Umpleby, A.M.3
-
50
-
-
0142030040
-
Plasma adiponectin increases postprandially in obese, but not in lean, subjects
-
English PJ, Coughlin SR, Hayden K, Malik IA, Wilding JP. Plasma adiponectin increases postprandially in obese, but not in lean, subjects. Obesity Research 2003; 11: 839-44.
-
(2003)
Obesity Research
, vol.11
, pp. 839-844
-
-
English, P.J.1
Coughlin, S.R.2
Hayden, K.3
Malik, I.A.4
Wilding, J.P.5
-
51
-
-
79955602730
-
Definition of postprandial lipaemia
-
Kolovou GD, Mikhailidis DP, Nordestgaard BG, Bilianou H, Panotopoulos G. Definition of postprandial lipaemia. Current Vascular Pharmacology 2011; 9: 292-301.
-
(2011)
Current Vascular Pharmacology
, vol.9
, pp. 292-301
-
-
Kolovou, G.D.1
Mikhailidis, D.P.2
Nordestgaard, B.G.3
Bilianou, H.4
Panotopoulos, G.5
-
52
-
-
79955595080
-
Diagnostic value of postprandial triglyceride testing in healthy subjects: A metaanalysis
-
Mihas C, Kolovou GD, Mikhailidis DP, et al. Diagnostic value of postprandial triglyceride testing in healthy subjects: a metaanalysis. Current Vascular Pharmacology 2011; 9: 271-80.
-
(2011)
Current Vascular Pharmacology
, vol.9
, pp. 271-280
-
-
Mihas, C.1
Kolovou, G.D.2
Mikhailidis, D.P.3
-
53
-
-
79955582390
-
Assessment and clinical relevance of non-fasting and postprandial triglycerides: An expert panel statement
-
Kolovou GD, Mikhailidis DP, Kovar J, et al. Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement. Current Vascular Pharmacology 2011; 9: 258-70.
-
(2011)
Current Vascular Pharmacology
, vol.9
, pp. 258-270
-
-
Kolovou, G.D.1
Mikhailidis, D.P.2
Kovar, J.3
-
54
-
-
0034639491
-
Hyperinsulinemia, hyperglycemia, and impaired hemostasis: The Framingham Offspring Study
-
Meigs JB, Mittleman MA, Nathan DM, et al. Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. JAMA 2000; 283: 221-8.
-
(2000)
JAMA
, vol.283
, pp. 221-228
-
-
Meigs, J.B.1
Mittleman, M.A.2
Nathan, D.M.3
-
56
-
-
77957313606
-
Pathophysiology of the proatherothrombotic state in the metabolic syndrome
-
Palomo I, Moore-Carrasco R, Alarcon M, et al. Pathophysiology of the proatherothrombotic state in the metabolic syndrome. Front Biosci (Schol Ed) 2010; 2: 194-208.
-
(2010)
Front Biosci (Schol Ed)
, vol.2
, pp. 194-208
-
-
Palomo, I.1
Moore-Carrasco, R.2
Alarcon, M.3
-
57
-
-
0033860359
-
Insulin resistance and cardiovascular disease
-
Ginsberg HN. Insulin resistance and cardiovascular disease. J Clinical Investigation 2000; 106: 453-8.
-
(2000)
J Clinical Investigation
, vol.106
, pp. 453-458
-
-
Ginsberg, H.N.1
-
58
-
-
0036322988
-
Obesity, haemostasis and the fibrinolytic system
-
Mertens I, Van Gaal LF. Obesity, haemostasis and the fibrinolytic system. Obesity Reviews 2002; 3: 85-101.
-
(2002)
Obesity Reviews
, vol.3
, pp. 85-101
-
-
Mertens, I.1
van Gaal, L.F.2
-
59
-
-
0033231294
-
Association of nonalcoholic fatty liver disease with insulin resistance
-
Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, et al. Association of nonalcoholic fatty liver disease with insulin resistance. American J Medicine 1999; 107: 450-5.
-
(1999)
American J Medicine
, vol.107
, pp. 450-455
-
-
Marchesini, G.1
Brizi, M.2
Morselli-Labate, A.M.3
Bianchi, G.4
-
60
-
-
0031471127
-
Genotype-specific transcriptional regulation of PAI-1 expression by hypertriglyceridemic VLDL and Lp(a) in cultured human endothelial cells
-
Li XN, Grenett HE, Benza RL, et al. Genotype-specific transcriptional regulation of PAI-1 expression by hypertriglyceridemic VLDL and Lp(a) in cultured human endothelial cells. Arteriosclerosis Thrombosis and Vascular Biology 1997; 17: 3215-23.
-
(1997)
Arteriosclerosis Thrombosis and Vascular Biology
, vol.17
, pp. 3215-3223
-
-
Li, X.N.1
Grenett, H.E.2
Benza, R.L.3
-
62
-
-
0030893613
-
Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome
-
Velazquez EM, Mendoza SG, Wang P, Glueck CJ. Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome. Metabolism: Clinical and Experimental 1997; 46: 454-7.
-
(1997)
Metabolism: Clinical and Experimental
, vol.46
, pp. 454-457
-
-
Velazquez, E.M.1
Mendoza, S.G.2
Wang, P.3
Glueck, C.J.4
-
63
-
-
50049125341
-
Metformin protects the brain against the oxidative imbalance promoted by type 2 diabetes
-
Correia S, Carvalho C, Santos MS, et al. Metformin protects the brain against the oxidative imbalance promoted by type 2 diabetes. Medicinal Chemistry 2008; 4: 358-64.
-
(2008)
Medicinal Chemistry
, vol.4
, pp. 358-364
-
-
Correia, S.1
Carvalho, C.2
Santos, M.S.3
-
64
-
-
58149330641
-
How does blood glucose control with metformin influence intensive insulin protocols? Evidence for involvement of oxidative stress and inflammatory cytokines
-
Ansari G, Mojtahedzadeh M, Kajbaf F, et al. How does blood glucose control with metformin influence intensive insulin protocols? Evidence for involvement of oxidative stress and inflammatory cytokines. Advances in Therapy 2008; 25: 681-702.
-
(2008)
Advances in Therapy
, vol.25
, pp. 681-702
-
-
Ansari, G.1
Mojtahedzadeh, M.2
Kajbaf, F.3
-
65
-
-
0030975615
-
Production of plasminogen activator inhibitor 1 by human adipose tissue: Possible link between visceral fat accumulation and vascular disease
-
Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I. Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes 1997; 46: 860-7.
-
(1997)
Diabetes
, vol.46
, pp. 860-867
-
-
Alessi, M.C.1
Peiretti, F.2
Morange, P.3
Henry, M.4
Nalbone, G.5
Juhan-Vague, I.6
-
66
-
-
0033028415
-
Expression of plasminogen activator inhibitor-1 in human adipose tissue: A role for TNF-alpha?
-
Cigolini M, Tonoli M, Borgato L, et al. Expression of plasminogen activator inhibitor-1 in human adipose tissue: a role for TNF-alpha? Atherosclerosis 1999; 143: 81-90.
-
(1999)
Atherosclerosis
, vol.143
, pp. 81-90
-
-
Cigolini, M.1
Tonoli, M.2
Borgato, L.3
-
67
-
-
0037408460
-
Differential mononuclear cell activity and endothelial inflammation in coronary artery disease and cardiac syndrome X
-
Lin CP, Lin WT, Leu HB, Wu TC, Chen JW. Differential mononuclear cell activity and endothelial inflammation in coronary artery disease and cardiac syndrome X. International J Cardiology 2003; 89: 53-62.
-
(2003)
International J Cardiology
, vol.89
, pp. 53-62
-
-
Lin, C.P.1
Lin, W.T.2
Leu, H.B.3
Wu, T.C.4
Chen, J.W.5
-
69
-
-
0032725206
-
Mechanisms of cellular activation by platelet microparticles
-
Barry OP, FitzGerald GA. Mechanisms of cellular activation by platelet microparticles. Thrombosis and Haemostasis 1999; 82: 794-800.
-
(1999)
Thrombosis and Haemostasis
, vol.82
, pp. 794-800
-
-
Barry, O.P.1
Fitzgerald, G.A.2
-
70
-
-
2942517677
-
Role of tissue factor in hemostasis, thrombosis, and vascular development
-
Mackman N. Role of tissue factor in hemostasis, thrombosis, and vascular development. Arteriosclerosis Thrombosis and Vascular Biology 2004; 24: 1015-22.
-
(2004)
Arteriosclerosis Thrombosis and Vascular Biology
, vol.24
, pp. 1015-1022
-
-
Mackman, N.1
-
72
-
-
0034966562
-
Plasma levels of free and total TFPI, relationship with cardiovascular risk factors and endothelial cell markers
-
Morange PE, Renucci JF, Charles MA, et al. Plasma levels of free and total TFPI, relationship with cardiovascular risk factors and endothelial cell markers. Thrombosis and Haemostasis 2001; 85: 999-1003.
-
(2001)
Thrombosis and Haemostasis
, vol.85
, pp. 999-1003
-
-
Morange, P.E.1
Renucci, J.F.2
Charles, M.A.3
-
73
-
-
0028903346
-
Lipoproteins and thrombosis: Effects of lipid lowering
-
Miller GJ. Lipoproteins and thrombosis: effects of lipid lowering. Current Opinion in Lipidology 1995; 6: 38-42.
-
(1995)
Current Opinion in Lipidology
, vol.6
, pp. 38-42
-
-
Miller, G.J.1
-
74
-
-
3543065104
-
Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects: The BIGPRO1 Study. Biguanides and the Prevention of the Risk of Obesity
-
Charles MA, Morange P, Eschwege E, Andre P, Vague P, Juhan-Vague I. Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects: the BIGPRO1 Study. Biguanides and the Prevention of the Risk of Obesity. Diabetes Care 1998; 21: 1967-72.
-
(1998)
Diabetes Care
, vol.21
, pp. 1967-1972
-
-
Charles, M.A.1
Morange, P.2
Eschwege, E.3
Andre, P.4
Vague, P.5
Juhan-Vague, I.6
-
76
-
-
0025134778
-
Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1
-
Landin K, Stigendal L, Eriksson E, Krotkiewski M, Risberg B, Tengborn L, Smith U. Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. Metabolism: Clinical and Experimental 1990; 39: 1044-8.
-
(1990)
Metabolism: Clinical and Experimental
, vol.39
, pp. 1044-1048
-
-
Landin, K.1
Stigendal, L.2
Eriksson, E.3
Krotkiewski, M.4
Risberg, B.5
Tengborn, L.6
Smith, U.7
-
77
-
-
0020670593
-
Simulating the diabetic environment modifies in vitro prostacyclin synthesis
-
Jeremy JY, Mikhailidis DP, Dandona P. Simulating the diabetic environment modifies in vitro prostacyclin synthesis. Diabetes 1983; 32: 217-21.
-
(1983)
Diabetes
, vol.32
, pp. 217-221
-
-
Jeremy, J.Y.1
Mikhailidis, D.P.2
Dandona, P.3
-
80
-
-
0032936725
-
Evidence for a common antecedent?
-
Yudkin JS. Abnormalities of coagulation and fibrinolysis in insulin resistance
-
Yudkin JS. Abnormalities of coagulation and fibrinolysis in insulin resistance. Evidence for a common antecedent? Diabetes Care 1999; 22 Suppl 3: C25-30.
-
(1999)
Diabetes Care
, vol.22
, Issue.SUPPL. 3
-
-
-
81
-
-
1242330832
-
Impact of alpha-tocopherol and vitamin C on endothelial markers in rats with streptozotocin-induced diabetes
-
Haidara MA, Khloussy H, Ammar H, Aal Kassem LA. Impact of alpha-tocopherol and vitamin C on endothelial markers in rats with streptozotocin-induced diabetes. Med Sci Monit 2004; 10: BR41-6.
-
(2004)
Med Sci Monit
, vol.10
-
-
Haidara, M.A.1
Khloussy, H.2
Ammar, H.3
Aal Kassem, L.A.4
-
82
-
-
11344279659
-
C-reactive protein levels and outcomes after statin therapy
-
Ridker PM, Cannon CP, Morrow D, et al. C-reactive protein levels and outcomes after statin therapy. New England J Medicine 2005; 352: 20-8.
-
(2005)
New England J Medicine
, vol.352
, pp. 20-28
-
-
Ridker, P.M.1
Cannon, C.P.2
Morrow, D.3
-
83
-
-
0142119459
-
Effects of statins on nonlipid serum markers associated with cardiovascular disease: A systematic review
-
Balk EM, Lau J, Goudas LC, et al. Effects of statins on nonlipid serum markers associated with cardiovascular disease: a systematic review. Annals of Internal Medicine 2003; 139: 670-82.
-
(2003)
Annals of Internal Medicine
, vol.139
, pp. 670-682
-
-
Balk, E.M.1
Lau, J.2
Goudas, L.C.3
-
85
-
-
77649180644
-
In vitro antioxidant activity of pravastatin provides vascular protection
-
Kassan M, Montero MJ, Sevilla MA. In vitro antioxidant activity of pravastatin provides vascular protection. European J Pharmacology 2010; 630: 107-11.
-
(2010)
European J Pharmacology
, vol.630
, pp. 107-111
-
-
Kassan, M.1
Montero, M.J.2
Sevilla, M.A.3
-
87
-
-
76149092815
-
Fenofibrate reduces systemic inflammation markers independent of its effects on lipid and glucose metabolism in patients with the metabolic syndrome
-
Belfort R, Berria R, Cornell J, Cusi K. Fenofibrate reduces systemic inflammation markers independent of its effects on lipid and glucose metabolism in patients with the metabolic syndrome. J Clinical Endocrinology & Metabolism 2010; 95: 829-36.
-
(2010)
J Clinical Endocrinology & Metabolism
, vol.95
, pp. 829-836
-
-
Belfort, R.1
Berria, R.2
Cornell, J.3
Cusi, K.4
-
88
-
-
65649113959
-
The role of statins for the primary and secondary prevention of coronary heart disease in women
-
Tziomalos K, Kakafika AI, Athyros VG, Karagiannis A, Mikhailidis DP. The role of statins for the primary and secondary prevention of coronary heart disease in women. Current Pharmaceutical Design 2009; 15: 1054-62.
-
(2009)
Current Pharmaceutical Design
, vol.15
, pp. 1054-1062
-
-
Tziomalos, K.1
Kakafika, A.I.2
Athyros, V.G.3
Karagiannis, A.4
Mikhailidis, D.P.5
-
89
-
-
64749110885
-
Pleiotropic effects of statins--clinical evidence
-
Athyros VG, Kakafika AI, Tziomalos K, Karagiannis A, Mikhailidis DP. Pleiotropic effects of statins--clinical evidence. Current Pharmaceutical Design 2009; 15: 479-89.
-
(2009)
Current Pharmaceutical Design
, vol.15
, pp. 479-489
-
-
Athyros, V.G.1
Kakafika, A.I.2
Tziomalos, K.3
Karagiannis, A.4
Mikhailidis, D.P.5
-
91
-
-
0030837996
-
High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells
-
Cosentino F, Hishikawa K, Katusic ZS, Luscher TF. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 1997; 96: 25-8.
-
(1997)
Circulation
, vol.96
, pp. 25-28
-
-
Cosentino, F.1
Hishikawa, K.2
Katusic, Z.S.3
Luscher, T.F.4
-
92
-
-
58149166857
-
Different effects of angiotensin converting enzyme inhibitors on endothelin-1 and nitric oxide balance in human vascular endothelial cells: Evidence of an oxidant-sensitive pathway
-
Desideri G, Grassi D, Croce G, Bocale R, Tiberti S, Evangelista S, Necozione S, Di Orio F, Ferri C. Different effects of angiotensin converting enzyme inhibitors on endothelin-1 and nitric oxide balance in human vascular endothelial cells: evidence of an oxidant-sensitive pathway. Mediators of Inflammation 2008; 2008: 305087.
-
(2008)
Mediators of Inflammation
, vol.2008
, pp. 305087
-
-
Desideri, G.1
Grassi, D.2
Croce, G.3
Bocale, R.4
Tiberti, S.5
Evangelista, S.6
Necozione, S.7
Di Orio, F.8
Ferri, C.9
-
93
-
-
82055173308
-
The mechanism underlying the development of hypertension in STZ-induced diabetic rats
-
Haidara MA, Desoky A, Khlousy H, Sebaee H. The mechanism underlying the development of hypertension in STZ-induced diabetic rats. Prog Med Res 2004; 2: 30.
-
(2004)
Prog Med Res
, vol.2
, pp. 30
-
-
Haidara, M.A.1
Desoky, A.2
Khlousy, H.3
Sebaee, H.4
-
95
-
-
0030025673
-
Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system
-
Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system. New England J Medicine 1996; 334: 374-81.
-
(1996)
New England J Medicine
, vol.334
, pp. 374-381
-
-
Reaven, G.M.1
Lithell, H.2
Landsberg, L.3
-
96
-
-
75749101030
-
Specific and pronounced impacts of lisinopril and lisinopril plus simvastatin on erythrocyte antioxidant enzymes
-
Kaminsky Y, Suslikov A, Kosenko E. Specific and pronounced impacts of lisinopril and lisinopril plus simvastatin on erythrocyte antioxidant enzymes. J Clinical Pharmacology 2010; 50: 180-7.
-
(2010)
J Clinical Pharmacology
, vol.50
, pp. 180-187
-
-
Kaminsky, Y.1
Suslikov, A.2
Kosenko, E.3
-
97
-
-
0043128821
-
Endothelial dysfunction: Clinical strategies for treating oxidant stress
-
Fenster BE, Tsao PS, Rockson SG. Endothelial dysfunction: clinical strategies for treating oxidant stress. American Heart Journal 2003; 146: 218-26.
-
(2003)
American Heart Journal
, vol.146
, pp. 218-226
-
-
Fenster, B.E.1
Tsao, P.S.2
Rockson, S.G.3
-
98
-
-
0035048905
-
Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: A unifying hypothesis
-
Dzau VJ. Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension 2001; 37: 1047-52.
-
(2001)
Hypertension
, vol.37
, pp. 1047-1052
-
-
Dzau, V.J.1
-
100
-
-
4644310560
-
Role of oxidative modifications in atherosclerosis
-
Stocker R, Keaney JF, Jr. Role of oxidative modifications in atherosclerosis. Physiological Reviews 2004; 84: 1381-478.
-
(2004)
Physiological Reviews
, vol.84
, pp. 1381-1478
-
-
Stocker, R.1
Keaney Jr., J.F.2
-
101
-
-
85030434746
-
Increased oxidative stress in obesity and its impact on metabolic syndrome
-
Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clinical Investigation 2004; 114: 1752-61.
-
(2004)
J Clinical Investigation
, vol.114
, pp. 1752-1761
-
-
Furukawa, S.1
Fujita, T.2
Shimabukuro, M.3
-
102
-
-
0031930768
-
Signal transduction in hepatic stellate cells
-
Pinzani M, Marra F, Carloni V. Signal transduction in hepatic stellate cells. Liver 1998; 18: 2-13.
-
(1998)
Liver
, vol.18
, pp. 2-13
-
-
Pinzani, M.1
Marra, F.2
Carloni, V.3
-
103
-
-
0029073101
-
Mitochondrial oxidative phosphorylation and intracellular glutathione compartmentation during rat liver regeneration
-
Vendemiale G, Guerrieri F, Grattagliano I, Didonna D, Muolo L, Altomare E. Mitochondrial oxidative phosphorylation and intracellular glutathione compartmentation during rat liver regeneration. Hepatology 1995; 21: 1450-4.
-
(1995)
Hepatology
, vol.21
, pp. 1450-1454
-
-
Vendemiale, G.1
Guerrieri, F.2
Grattagliano, I.3
Didonna, D.4
Muolo, L.5
Altomare, E.6
-
104
-
-
46749149676
-
Oxidative stress-induced risk factors associated with the metabolic syndrome: A unifying hypothesis
-
Grattagliano I, Palmieri VO, Portincasa P, Moschetta A, Palasciano G. Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis. J Nutritional Biochemistry 2008; 19: 491-504.
-
(2008)
J Nutritional Biochemistry
, vol.19
, pp. 491-504
-
-
Grattagliano, I.1
Palmieri, V.O.2
Portincasa, P.3
Moschetta, A.4
Palasciano, G.5
-
105
-
-
0033165758
-
Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery
-
Kawano H, Motoyama T, Hirashima O, et al. Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J the American College of Cardiology 1999; 34: 146-54.
-
(1999)
J the American College of Cardiology
, vol.34
, pp. 146-154
-
-
Kawano, H.1
Motoyama, T.2
Hirashima, O.3
-
106
-
-
0035856980
-
Biochemistry and molecular cell biology of diabetic complications
-
Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-20.
-
(2001)
Nature
, vol.414
, pp. 813-820
-
-
Brownlee, M.1
-
107
-
-
0025732948
-
Role of oxidative stress in development of complications in diabetes
-
Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40: 405-12.
-
(1991)
Diabetes
, vol.40
, pp. 405-412
-
-
Baynes, J.W.1
-
108
-
-
67649234171
-
A new perspective on therapeutic inhibition of advanced glycation in diabetic microvascular complications: Common downstream endpoints achieved through disparate therapeutic approaches?
-
Sourris KC, Harcourt BE, Forbes JM. A new perspective on therapeutic inhibition of advanced glycation in diabetic microvascular complications: common downstream endpoints achieved through disparate therapeutic approaches? American J Nephrology 2009; 30: 323-35.
-
(2009)
American J Nephrology
, vol.30
, pp. 323-335
-
-
Sourris, K.C.1
Harcourt, B.E.2
Forbes, J.M.3
-
109
-
-
0035180299
-
Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site
-
Du XL, Edelstein D, Dimmeler S, Ju Q, Sui C, Brownlee M. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clinical Investigation 2001; 108: 1341-8.
-
(2001)
J Clinical Investigation
, vol.108
, pp. 1341-1348
-
-
Du, X.L.1
Edelstein, D.2
Dimmeler, S.3
Ju, Q.4
Sui, C.5
Brownlee, M.6
-
111
-
-
7944229937
-
Coenzyme Q10 and diabetic endotheliopathy: Oxidative stress and the 'recoupling hypothesis'
-
Chew GT, Watts GF. Coenzyme Q10 and diabetic endotheliopathy: oxidative stress and the 'recoupling hypothesis'. QJM 2004; 97: 537-48.
-
(2004)
QJM
, vol.97
, pp. 537-548
-
-
Chew, G.T.1
Watts, G.F.2
-
112
-
-
0035985081
-
Vascular function, insulin resistance and fatty acids
-
Steinberg HO, Baron AD. Vascular function, insulin resistance and fatty acids. Diabetologia 2002; 45: 623-34.
-
(2002)
Diabetologia
, vol.45
, pp. 623-634
-
-
Steinberg, H.O.1
Baron, A.D.2
-
113
-
-
0035923560
-
Homocysteine impairs the nitric oxide synthase pathway: Role of asymmetric dimethylarginine
-
Stuhlinger MC, Tsao PS, Her JH, et al. Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation 2001; 104: 2569-75.
-
(2001)
Circulation
, vol.104
, pp. 2569-2575
-
-
Stuhlinger, M.C.1
Tsao, P.S.2
Her, J.H.3
-
114
-
-
4344666158
-
Tumor necrosis factor and its potential role in insulin resistance and nonalcoholic fatty liver disease
-
Diehl AM. Tumor necrosis factor and its potential role in insulin resistance and nonalcoholic fatty liver disease. Clinics in Liver Disease 2004; 8: 619-38, x.
-
(2004)
Clinics in Liver Disease
, vol.8
-
-
Diehl, A.M.1
-
115
-
-
13544258741
-
Nonalcoholic steatohepatitis: Recent advances from experimental models to clinical management
-
Portincasa P, Grattagliano I, Palmieri VO, Palasciano G. Nonalcoholic steatohepatitis: recent advances from experimental models to clinical management. Clinical Biochemistry 2005; 38: 203-17.
-
(2005)
Clinical Biochemistry
, vol.38
, pp. 203-217
-
-
Portincasa, P.1
Grattagliano, I.2
Palmieri, V.O.3
Palasciano, G.4
-
116
-
-
4344628555
-
The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease
-
McCullough AJ. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clinics in Liver Disease 2004; 8: 521-33, viii.
-
(2004)
Clinics in Liver Disease
, vol.8
-
-
McCullough, A.J.1
-
117
-
-
24044536090
-
Recent concepts in non-alcoholic fatty liver disease
-
Adams LA, Angulo P. Recent concepts in non-alcoholic fatty liver disease. Diabetic Medicine 2005; 22: 1129-33.
-
(2005)
Diabetic Medicine
, vol.22
, pp. 1129-1133
-
-
Adams, L.A.1
Angulo, P.2
-
118
-
-
33846264060
-
Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: The plot thickens
-
Targher G. Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens. Diabetic Medicine 2007; 24: 1-6.
-
(2007)
Diabetic Medicine
, vol.24
, pp. 1-6
-
-
Targher, G.1
-
119
-
-
79959795387
-
NASH: A global health problem
-
Sanyal AJ. NASH: A global health problem. Hepatology Research 2011; 41: 670-4.
-
(2011)
Hepatology Research
, vol.41
, pp. 670-674
-
-
Sanyal, A.J.1
-
120
-
-
18244364864
-
NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome
-
Chitturi S, Abeygunasekera S, Farrell GC, et al. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002; 35: 373-9.
-
(2002)
Hepatology
, vol.35
, pp. 373-379
-
-
Chitturi, S.1
Abeygunasekera, S.2
Farrell, G.C.3
-
121
-
-
65549122652
-
Metabolic disturbances in non-alcoholic fatty liver disease
-
Byrne CD, Olufadi R, Bruce KD, Cagampang FR, Ahmed MH. Metabolic disturbances in non-alcoholic fatty liver disease. Clinical Science (London) 2009; 116: 539-64.
-
(2009)
Clinical Science (London)
, vol.116
, pp. 539-564
-
-
Byrne, C.D.1
Olufadi, R.2
Bruce, K.D.3
Cagampang, F.R.4
Ahmed, M.H.5
-
122
-
-
47249150243
-
Non-alcoholic fatty liver disease-new view
-
Raszeja-Wyszomirska J, Lawniczak M, Marlicz W, Miezynska-Kurtycz J, Milkiewicz P. [Non-alcoholic fatty liver disease-new view]. Pol Merkur Lekarski 2008; 24: 568-71.
-
(2008)
Pol Merkur Lekarski
, vol.24
, pp. 568-571
-
-
Raszeja-Wyszomirska, J.1
Lawniczak, M.2
Marlicz, W.3
Miezynska-Kurtycz, J.4
Milkiewicz, P.5
-
123
-
-
43649091349
-
Prevalence of the metabolic syndrome among U.S. adolescents using the definition from the International Diabetes Federation
-
Ford ES, Li C, Zhao G, Pearson WS, Mokdad AH. Prevalence of the metabolic syndrome among U.S. adolescents using the definition from the International Diabetes Federation. Diabetes Care 2008; 31: 587-9.
-
(2008)
Diabetes Care
, vol.31
, pp. 587-589
-
-
Ford, E.S.1
Li, C.2
Zhao, G.3
Pearson, W.S.4
Mokdad, A.H.5
-
124
-
-
0033625733
-
Insulin resistance influence iron metabolism and hepatic steatosis in type II diabetes
-
Vigano M, Vergani A, Trombini P, Paleari F, Piperno A. Insulin resistance influence iron metabolism and hepatic steatosis in type II diabetes. Gastroenterology 2000; 118: 986-7.
-
(2000)
Gastroenterology
, vol.118
, pp. 986-987
-
-
Vigano, M.1
Vergani, A.2
Trombini, P.3
Paleari, F.4
Piperno, A.5
-
125
-
-
33747090739
-
Liver breath tests non-invasively predict higher stages of non-alcoholic steatohepatitis
-
Portincasa P, Grattagliano I, Lauterburg BH, Palmieri VO, Palasciano G, Stellaard F. Liver breath tests non-invasively predict higher stages of non-alcoholic steatohepatitis. Clinical Science (London) 2006; 111: 135-43.
-
(2006)
Clinical Science (London)
, vol.111
, pp. 135-143
-
-
Portincasa, P.1
Grattagliano, I.2
Lauterburg, B.H.3
Palmieri, V.O.4
Palasciano, G.5
Stellaard, F.6
-
126
-
-
0032171686
-
Non-alcoholic steatohepatitis (NASH): A disease of emerging identity and importance
-
James OF, Day CP. Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance. J Hepatology 1998; 29: 495-501.
-
(1998)
J Hepatology
, vol.29
, pp. 495-501
-
-
James, O.F.1
Day, C.P.2
-
127
-
-
78649890465
-
Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: A post-hoc analysis
-
Athyros VG, Tziomalos K, Gossios TD, et al. Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis. Lancet 2010; 376: 1916-22.
-
(2010)
Lancet
, vol.376
, pp. 1916-1922
-
-
Athyros, V.G.1
Tziomalos, K.2
Gossios, T.D.3
-
128
-
-
79953322846
-
Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients
-
Manousou P, Kalambokis G, Grillo F, et al. Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients. Liver International 2011; 31: 730-9.
-
(2011)
Liver International
, vol.31
, pp. 730-739
-
-
Manousou, P.1
Kalambokis, G.2
Grillo, F.3
-
129
-
-
72049125105
-
Hepatitis C virus and nonalcoholic Fatty liver disease: Similar risk factors for necroinflammation, fibrosis, and cirrhosis
-
author reply 97
-
Comparcola D, Alisi A, Nobili V. Hepatitis C virus and nonalcoholic Fatty liver disease: similar risk factors for necroinflammation, fibrosis, and cirrhosis. Clinical Gastroenterology and Hepatology 2010; 8: 97; author reply 97.
-
(2010)
Clinical Gastroenterology and Hepatology
, vol.8
, pp. 97
-
-
Comparcola, D.1
Alisi, A.2
Nobili, V.3
-
130
-
-
0141682739
-
Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome
-
Sanyal AJ, Contos MJ, Sterling RK, et al. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome. American J Gastroenterology 2003; 98: 2064-71.
-
(2003)
American J Gastroenterology
, vol.98
, pp. 2064-2071
-
-
Sanyal, A.J.1
Contos, M.J.2
Sterling, R.K.3
-
131
-
-
79959453427
-
Metabolic syndrome, chronic kidney disease, and cardiovascular disease: A dynamic and life-threatening triad
-
Raimundo M, Lopes JA. Metabolic syndrome, chronic kidney disease, and cardiovascular disease: a dynamic and life-threatening triad. Cardiol Res Pract 2011; 2011: 747861.
-
(2011)
Cardiol Res Pract
, vol.2011
, pp. 747861
-
-
Raimundo, M.1
Lopes, J.A.2
-
132
-
-
33748141662
-
Plasma aldosterone is independently associated with the metabolic syndrome
-
Bochud M, Nussberger J, Bovet P, et al. Plasma aldosterone is independently associated with the metabolic syndrome. Hypertension 2006; 48: 239-45.
-
(2006)
Hypertension
, vol.48
, pp. 239-245
-
-
Bochud, M.1
Nussberger, J.2
Bovet, P.3
-
133
-
-
33847048251
-
Association of adrenal steroids with hypertension and the metabolic syndrome in blacks
-
Kidambi S, Kotchen JM, Grim CE, et al. Association of adrenal steroids with hypertension and the metabolic syndrome in blacks. Hypertension 2007; 49: 704-11.
-
(2007)
Hypertension
, vol.49
, pp. 704-711
-
-
Kidambi, S.1
Kotchen, J.M.2
Grim, C.E.3
-
134
-
-
34548419736
-
Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients
-
Colussi G, Catena C, Lapenna R, Nadalini E, Chiuch A, Sechi LA. Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients. Diabetes Care 2007; 30: 2349-54.
-
(2007)
Diabetes Care
, vol.30
, pp. 2349-2354
-
-
Colussi, G.1
Catena, C.2
Lapenna, R.3
Nadalini, E.4
Chiuch, A.5
Sechi, L.A.6
-
135
-
-
34548216220
-
Spotlight on renin. The renin system, salt-sensitivity and metabolic syndrome
-
Fujita T. Spotlight on renin. The renin system, salt-sensitivity and metabolic syndrome. J the Renin-Angiotensin-Aldosterone System 2006; 7: 181-3.
-
(2006)
J the Renin-Angiotensin-Aldosterone System
, vol.7
, pp. 181-183
-
-
Fujita, T.1
-
136
-
-
34547630857
-
Sympathoexcitation by Oxidative Stress in the Brain Mediates Arterial Pressure Elevation in Salt-Sensitive Hypertension
-
Fujita M, Ando K, Nagae A, Fujita T. Sympathoexcitation by Oxidative Stress in the Brain Mediates Arterial Pressure Elevation in Salt-Sensitive Hypertension. Hypertension 2007; 50: 360-7.
-
(2007)
Hypertension
, vol.50
, pp. 360-367
-
-
Fujita, M.1
Ando, K.2
Nagae, A.3
Fujita, T.4
-
137
-
-
1242342716
-
Superoxide is involved in the central nervous system activation and sympathoexcitation of myocardial infarction-induced heart failure
-
Lindley TE, Doobay MF, Sharma RV, Davisson RL. Superoxide is involved in the central nervous system activation and sympathoexcitation of myocardial infarction-induced heart failure. Circulation Research 2004; 94: 402-9.
-
(2004)
Circulation Research
, vol.94
, pp. 402-409
-
-
Lindley, T.E.1
Doobay, M.F.2
Sharma, R.V.3
Davisson, R.L.4
-
139
-
-
0347320490
-
The role of oxidative stress in salt-induced hypertension
-
Bayorh MA, Ganafa AA, Socci RR, Silvestrov N, Abukhalaf IK. The role of oxidative stress in salt-induced hypertension. American J Hypertension 2004; 17: 31-6.
-
(2004)
American J Hypertension
, vol.17
, pp. 31-36
-
-
Bayorh, M.A.1
Ganafa, A.A.2
Socci, R.R.3
Silvestrov, N.4
Abukhalaf, I.K.5
-
140
-
-
33748157529
-
Protective effect of potassium against the hypertensive cardiac dysfunction: Association with reactive oxygen species reduction
-
Matsui H, Shimosawa T, Uetake Y, et al. Protective effect of potassium against the hypertensive cardiac dysfunction: association with reactive oxygen species reduction. Hypertension 2006; 48: 225-31.
-
(2006)
Hypertension
, vol.48
, pp. 225-231
-
-
Matsui, H.1
Shimosawa, T.2
Uetake, Y.3
-
141
-
-
11844263385
-
High dietary fat induces NADPH oxidase-associated oxidative stress and inflammation in rat cerebral cortex
-
Zhang X, Dong F, Ren J, Driscoll MJ, Culver B. High dietary fat induces NADPH oxidase-associated oxidative stress and inflammation in rat cerebral cortex. Experimental Neurology 2005; 191: 318-325.
-
(2005)
Experimental Neurology
, vol.191
, pp. 318-325
-
-
Zhang, X.1
Dong, F.2
Ren, J.3
Driscoll, M.J.4
Culver, B.5
-
142
-
-
0024323773
-
The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents
-
Rocchini AP, Key J, Bondie D, et al. The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. New England J Medicine 1989; 321: 580-5.
-
(1989)
New England J Medicine
, vol.321
, pp. 580-585
-
-
Rocchini, A.P.1
Key, J.2
Bondie, D.3
-
143
-
-
33746743021
-
Enhanced sodium sensitivity and disturbed circadian rhythm of blood pressure in essential hypertension
-
Uzu T, Kimura G, Yamauchi A, et al. Enhanced sodium sensitivity and disturbed circadian rhythm of blood pressure in essential hypertension. J Hypertension 2006; 24: 1627-32.
-
(2006)
J Hypertension
, vol.24
, pp. 1627-1632
-
-
Uzu, T.1
Kimura, G.2
Yamauchi, A.3
-
144
-
-
0036318323
-
High-salt diet enhances insulin signaling and induces insulin resistance in Dahl salt-sensitive rats
-
Ogihara T, Asano T, Ando K, et al. High-salt diet enhances insulin signaling and induces insulin resistance in Dahl salt-sensitive rats. Hypertension 2002; 40: 83-9.
-
(2002)
Hypertension
, vol.40
, pp. 83-89
-
-
Ogihara, T.1
Asano, T.2
Ando, K.3
-
146
-
-
4544378858
-
Low micromolar concentrations of copper augment the impairment of endothelium-dependent relaxation of aortae from diabetic rabbits
-
Shukla N, Thompson CS, Angelini GD, Mikhailidis DP, Jeremy JY. Low micromolar concentrations of copper augment the impairment of endothelium-dependent relaxation of aortae from diabetic rabbits. Metabolism: Clinical and Experimental 2004; 53: 1315-21.
-
(2004)
Metabolism: Clinical and Experimental
, vol.53
, pp. 1315-1321
-
-
Shukla, N.1
Thompson, C.S.2
Angelini, G.D.3
Mikhailidis, D.P.4
Jeremy, J.Y.5
-
147
-
-
0034640107
-
Vascular superoxide production by NAD(P)H oxidase: Association with endothelial dysfunction and clinical risk factors
-
Guzik TJ, West NE, Black E, et al. Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. Circulation Research 2000; 86: E85-90.
-
(2000)
Circulation Research
, vol.86
-
-
Guzik, T.J.1
West, N.E.2
Black, E.3
-
148
-
-
25144453937
-
NADPH oxidase and endothelial cell function
-
Ray R, Shah AM. NADPH oxidase and endothelial cell function. Clinical Science 2005; 109: 217-226.
-
(2005)
Clinical Science
, vol.109
, pp. 217-226
-
-
Ray, R.1
Shah, A.M.2
-
149
-
-
0037399439
-
Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension
-
Landmesser U, Dikalov S, Price SR, et al. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clinical Investigation 2003; 111: 1201-9.
-
(2003)
J Clinical Investigation
, vol.111
, pp. 1201-1209
-
-
Landmesser, U.1
Dikalov, S.2
Price, S.R.3
-
151
-
-
4444268721
-
Factors related to the impact of antihypertensive treatment in antioxidant activities and oxidative stress by-products in human hypertension
-
Saez GT, Tormos C, Giner V, Chaves J, Lozano JV, Iradi A, Redon J. Factors related to the impact of antihypertensive treatment in antioxidant activities and oxidative stress by-products in human hypertension. American J Hypertension 2004; 17: 809-16.
-
(2004)
American J Hypertension
, vol.17
, pp. 809-816
-
-
Saez, G.T.1
Tormos, C.2
Giner, V.3
Chaves, J.4
Lozano, J.V.5
Iradi, A.6
Redon, J.7
-
153
-
-
49649087213
-
Do different vascular risk factors affect all arteries equally?
-
Paraskevas KI, Bessias N, Papas TT, Gekas CD, Andrikopoulos V, Mikhailidis DP. Do different vascular risk factors affect all arteries equally? Angiology 2008; 59: 397-401.
-
(2008)
Angiology
, vol.59
, pp. 397-401
-
-
Paraskevas, K.I.1
Bessias, N.2
Papas, T.T.3
Gekas, C.D.4
Andrikopoulos, V.5
Mikhailidis, D.P.6
-
154
-
-
0035834028
-
Induction of NAD(P)H oxidase by oxidized low-density lipoprotein in human endothelial cells: Antioxidative potential of hydroxymethylglutaryl coenzyme A reductase inhibitor therapy
-
Rueckschloss U, Galle J, Holtz J, Zerkowski HR, Morawietz H. Induction of NAD(P)H oxidase by oxidized low-density lipoprotein in human endothelial cells: antioxidative potential of hydroxymethylglutaryl coenzyme A reductase inhibitor therapy. Circulation 2001; 104: 1767-72.
-
(2001)
Circulation
, vol.104
, pp. 1767-1772
-
-
Rueckschloss, U.1
Galle, J.2
Holtz, J.3
Zerkowski, H.R.4
Morawietz, H.5
-
155
-
-
0033586639
-
Increased NADHoxidase - mediated superoxide production in the early stages of atherosclerosis: Evidence for involvement of the renin-angiotensin system
-
Warnholtz A, Nickenig G, Schulz E, et al. Increased NADHoxidase- mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. Circulation 1999; 99: 2027-33.
-
(1999)
Circulation
, vol.99
, pp. 2027-2033
-
-
Warnholtz, A.1
Nickenig, G.2
Schulz, E.3
-
156
-
-
0036186652
-
Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians
-
Weyer C, Yudkin JS, Stehouwer CD, Schalkwijk CG, Pratley RE, Tataranni PA. Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians. Atherosclerosis 2002; 161: 233-42.
-
(2002)
Atherosclerosis
, vol.161
, pp. 233-242
-
-
Weyer, C.1
Yudkin, J.S.2
Stehouwer, C.D.3
Schalkwijk, C.G.4
Pratley, R.E.5
Tataranni, P.A.6
-
157
-
-
34347350171
-
Chronic kidney disease: Effects on the cardiovascular system
-
Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation 2007; 116: 85-97.
-
(2007)
Circulation
, vol.116
, pp. 85-97
-
-
Schiffrin, E.L.1
Lipman, M.L.2
Mann, J.F.3
-
158
-
-
57049146797
-
Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease
-
Cachofeiro V, Goicochea M, de Vinuesa SG, Oubina P, Lahera V, Luno J. Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. Kidney International Supplement 2008: S4-9.
-
(2008)
Kidney International Supplement
-
-
Cachofeiro, V.1
Goicochea, M.2
de Vinuesa, S.G.3
Oubina, P.4
Lahera, V.5
Luno, J.6
-
159
-
-
33749623475
-
Oxidative stress and atherosclerosis in early chronic kidney disease
-
Zalba G, Fortuno A, Diez J. Oxidative stress and atherosclerosis in early chronic kidney disease. Nephrology Dialysis Transplantation 2006; 21: 2686-90.
-
(2006)
Nephrology Dialysis Transplantation
, vol.21
, pp. 2686-2690
-
-
Zalba, G.1
Fortuno, A.2
Diez, J.3
-
160
-
-
76749150027
-
Vascular disease and chronic renal failure: New insights
-
Nanayakkara PW, Gaillard CA. Vascular disease and chronic renal failure: new insights. Netherlands J Medicine 2010; 68: 5-14.
-
(2010)
Netherlands J Medicine
, vol.68
, pp. 5-14
-
-
Nanayakkara, P.W.1
Gaillard, C.A.2
-
161
-
-
33947305508
-
Statins and cardiovascular risk reduction in patients with chronic kidney disease and end-stage renal failure
-
Baber U, Toto RD, de Lemos JA. Statins and cardiovascular risk reduction in patients with chronic kidney disease and end-stage renal failure. American Heart Journal 2007; 153: 471-7.
-
(2007)
American Heart Journal
, vol.153
, pp. 471-477
-
-
Baber, U.1
Toto, R.D.2
de Lemos, J.A.3
-
162
-
-
33751009384
-
Oxidative stress is progressively enhanced with advancing stages of CKD
-
Dounousi E, Papavasiliou E, Makedou A, et al. Oxidative stress is progressively enhanced with advancing stages of CKD. American J Kidney Diseases 2006; 48: 752-60.
-
(2006)
American J Kidney Diseases
, vol.48
, pp. 752-760
-
-
Dounousi, E.1
Papavasiliou, E.2
Makedou, A.3
-
163
-
-
27744608003
-
Essential hypertension, progressive renal disease, and uric acid: A pathogenetic link?
-
Johnson RJ, Segal MS, Srinivas T, et al. Essential hypertension, progressive renal disease, and uric acid: a pathogenetic link? J the American Society of Nephrology 2005; 16: 1909-19.
-
(2005)
J the American Society of Nephrology
, vol.16
, pp. 1909-1919
-
-
Johnson, R.J.1
Segal, M.S.2
Srinivas, T.3
-
164
-
-
0031093278
-
Reassessing the cardiac risk profile in chronic hemodialysis patients: A hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors
-
Becker BN, Himmelfarb J, Henrich WL, Hakim RM. Reassessing the cardiac risk profile in chronic hemodialysis patients: a hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors. J the American Society of Nephrology 1997; 8: 475-86.
-
(1997)
J the American Society of Nephrology
, vol.8
, pp. 475-486
-
-
Becker, B.N.1
Himmelfarb, J.2
Henrich, W.L.3
Hakim, R.M.4
-
165
-
-
0033854483
-
Increased intracellular reactive oxygen species in patients with end-stage renal failure: Effect of hemodialysis
-
Tepel M, Echelmeyer M, Orie NN, Zidek W. Increased intracellular reactive oxygen species in patients with end-stage renal failure: effect of hemodialysis. Kidney International 2000; 58: 867-72.
-
(2000)
Kidney International
, vol.58
, pp. 867-872
-
-
Tepel, M.1
Echelmeyer, M.2
Orie, N.N.3
Zidek, W.4
-
167
-
-
21644436782
-
Oxidative stress is enhanced in correlation with renal dysfunction: Examination with the redox state of albumin
-
Terawaki H, Yoshimura K, Hasegawa T, et al. Oxidative stress is enhanced in correlation with renal dysfunction: examination with the redox state of albumin. Kidney International 2004; 66: 1988-93.
-
(2004)
Kidney International
, vol.66
, pp. 1988-1993
-
-
Terawaki, H.1
Yoshimura, K.2
Hasegawa, T.3
-
168
-
-
18844471606
-
Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure
-
Witko-Sarsat V, Friedlander M, Nguyen Khoa T, et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunology 1998; 161: 2524-32.
-
(1998)
J Immunology
, vol.161
, pp. 2524-2532
-
-
Witko-Sarsat, V.1
Friedlander, M.2
Nguyen Khoa, T.3
-
169
-
-
77449122756
-
Oxidative stress in renal dysfunction: Mechanisms, clinical sequelae and therapeutic options
-
Kao MP, Ang DS, Pall A, Struthers AD. Oxidative stress in renal dysfunction: mechanisms, clinical sequelae and therapeutic options. J Human Hypertension 2010; 24: 1-8.
-
(2010)
J Human Hypertension
, vol.24
, pp. 1-8
-
-
Kao, M.P.1
Ang, D.S.2
Pall, A.3
Struthers, A.D.4
-
170
-
-
0038353176
-
Oxidative stress in end-stage renal disease: An emerging threat to patient outcome
-
Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrology Dialysis Transplantation 2003; 18: 1272-80.
-
(2003)
Nephrology Dialysis Transplantation
, vol.18
, pp. 1272-1280
-
-
Locatelli, F.1
Canaud, B.2
Eckardt, K.U.3
Stenvinkel, P.4
Wanner, C.5
Zoccali, C.6
-
171
-
-
0029086172
-
Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure
-
Jackson P, Loughrey CM, Lightbody JH, McNamee PT, Young IS. Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clinical Chemistry 1995; 41: 1135-8.
-
(1995)
Clinical Chemistry
, vol.41
, pp. 1135-1138
-
-
Jackson, P.1
Loughrey, C.M.2
Lightbody, J.H.3
McNamee, P.T.4
Young, I.S.5
-
172
-
-
0028265472
-
Lipoperoxidation in plasma and red blood cells of patients undergoing haemodialysis: Vitamins A, E, and iron status
-
Peuchant E, Carbonneau MA, Dubourg L, et al. Lipoperoxidation in plasma and red blood cells of patients undergoing haemodialysis: vitamins A, E, and iron status. Free Radical Biology & Medicine 1994; 16: 339-46.
-
(1994)
Free Radical Biology & Medicine
, vol.16
, pp. 339-346
-
-
Peuchant, E.1
Carbonneau, M.A.2
Dubourg, L.3
-
173
-
-
34547185623
-
Oxidative stress and redox signalling in cardiac hypertrophy and heart failure
-
Seddon M, Looi YH, Shah AM. Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. Heart 2007; 93: 903-7.
-
(2007)
Heart
, vol.93
, pp. 903-907
-
-
Seddon, M.1
Looi, Y.H.2
Shah, A.M.3
-
175
-
-
77952423444
-
Endothelial dysfunction is associated with increased levels of biomarkers in essential hypertension
-
de la Sierra A, Larrousse M. Endothelial dysfunction is associated with increased levels of biomarkers in essential hypertension. J Human Hypertension 2010; 24: 373-379.
-
(2010)
J Human Hypertension
, vol.24
, pp. 373-379
-
-
de la Sierra, A.1
Larrousse, M.2
-
176
-
-
25644452089
-
Comparison of the effects of vitamins and/or mineral supplementation on glomerular and tubular dysfunction in type 2 diabetes
-
Farvid MS, Jalali M, Siassi F, Hosseini M. Comparison of the effects of vitamins and/or mineral supplementation on glomerular and tubular dysfunction in type 2 diabetes. Diabetes Care 2005; 28: 2458-64.
-
(2005)
Diabetes Care
, vol.28
, pp. 2458-2464
-
-
Farvid, M.S.1
Jalali, M.2
Siassi, F.3
Hosseini, M.4
-
178
-
-
0026755677
-
Effect of dietary supplementation with alphatocopherol on the oxidative modification of low density lipoprotein
-
Jialal I, Grundy SM. Effect of dietary supplementation with alphatocopherol on the oxidative modification of low density lipoprotein. J Lipid Research 1992; 33: 899-906.
-
(1992)
J Lipid Research
, vol.33
, pp. 899-906
-
-
Jialal, I.1
Grundy, S.M.2
-
180
-
-
0034126755
-
Vitamin E treatment of nonalcoholic steatohepatitis in children: A pilot study
-
Lavine JE. Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study. J Pediatrics 2000; 136: 734-8.
-
(2000)
J Pediatrics
, vol.136
, pp. 734-738
-
-
Lavine, J.E.1
-
181
-
-
0024260831
-
Effect of vitamin E supplementation on platelet thromboxane A2 production in type I diabetic patients. Doubleblind crossover trial
-
Gisinger C, Jeremy J, Speiser P, Mikhailidis D, Dandona P, Schernthaner G. Effect of vitamin E supplementation on platelet thromboxane A2 production in type I diabetic patients. Doubleblind crossover trial. Diabetes 1988; 37: 1260-4.
-
(1988)
Diabetes
, vol.37
, pp. 1260-1264
-
-
Gisinger, C.1
Jeremy, J.2
Speiser, P.3
Mikhailidis, D.4
Dandona, P.5
Schernthaner, G.6
-
182
-
-
59849084406
-
Evaluation of the effect of oxidative stress and vitamin E supplementation on renal function in rats with streptozotocin-induced Type 1 diabetes
-
Haidara MA, Mikhailidis DP, Rateb MA, et al. Evaluation of the effect of oxidative stress and vitamin E supplementation on renal function in rats with streptozotocin-induced Type 1 diabetes. J Diabetes and Its Complications 2009; 23: 130-6.
-
(2009)
J Diabetes and Its Complications
, vol.23
, pp. 130-136
-
-
Haidara, M.A.1
Mikhailidis, D.P.2
Rateb, M.A.3
-
183
-
-
45149111073
-
Severe liver steatosis correlates with nitrosative and oxidative stress in rats
-
Grattagliano I, Caraceni P, Calamita G, et al. Severe liver steatosis correlates with nitrosative and oxidative stress in rats. European J Clinical Investigation 2008; 38: 523-30.
-
(2008)
European J Clinical Investigation
, vol.38
, pp. 523-530
-
-
Grattagliano, I.1
Caraceni, P.2
Calamita, G.3
-
184
-
-
20044366744
-
Ascorbic acid selectively improves large elastic artery compliance in postmenopausal women
-
Moreau KL, Gavin KM, Plum AE, Seals DR. Ascorbic acid selectively improves large elastic artery compliance in postmenopausal women. Hypertension 2005; 45: 1107-12.
-
(2005)
Hypertension
, vol.45
, pp. 1107-1112
-
-
Moreau, K.L.1
Gavin, K.M.2
Plum, A.E.3
Seals, D.R.4
-
185
-
-
0030940959
-
Fruit and vegetables, and cardiovascular disease: A review
-
Ness AR, Powles JW. Fruit and vegetables, and cardiovascular disease: a review. International J Epidemiology 1997; 26: 1-13.
-
(1997)
International J Epidemiology
, vol.26
, pp. 1-13
-
-
Ness, A.R.1
Powles, J.W.2
-
186
-
-
31444443311
-
Fruit and vegetable consumption and stroke: Meta-analysis of cohort studies
-
He FJ, Nowson CA, MacGregor GA. Fruit and vegetable consumption and stroke: meta-analysis of cohort studies. Lancet 2006; 367: 320-6.
-
(2006)
Lancet
, vol.367
, pp. 320-326
-
-
He, F.J.1
Nowson, C.A.2
Macgregor, G.A.3
-
187
-
-
0037840165
-
Use of antioxidant vitamins for the prevention of cardiovascular disease: Meta-analysis of randomised trials
-
Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 2003; 361: 2017-23.
-
(2003)
Lancet
, vol.361
, pp. 2017-2023
-
-
Vivekananthan, D.P.1
Penn, M.S.2
Sapp, S.K.3
Hsu, A.4
Topol, E.J.5
-
188
-
-
33845336554
-
Randomized placebocontrolled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis
-
Dufour JF, Oneta CM, Gonvers JJ, et al. Randomized placebocontrolled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis. Clinical Gastroenterology and Hepatology 2006; 4: 1537-43.
-
(2006)
Clinical Gastroenterology and Hepatology
, vol.4
, pp. 1537-1543
-
-
Dufour, J.F.1
Oneta, C.M.2
Gonvers, J.J.3
-
189
-
-
0344742265
-
Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis
-
Harrison SA, Torgerson S, Hayashi P, Ward J, Schenker S. Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis. American J Gastroenterology 2003; 98: 2485-90.
-
(2003)
American J Gastroenterology
, vol.98
, pp. 2485-2490
-
-
Harrison, S.A.1
Torgerson, S.2
Hayashi, P.3
Ward, J.4
Schenker, S.5
-
190
-
-
77951874018
-
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis
-
Sanyal AJ, Chalasani N, Kowdley KV, et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. New England J Medicine 2010; 362: 1675-85.
-
(2010)
New England J Medicine
, vol.362
, pp. 1675-1685
-
-
Sanyal, A.J.1
Chalasani, N.2
Kowdley, K.V.3
-
191
-
-
55149106587
-
Nutritional supplementation for type 2 diabetes: A systematic review
-
Bartlett HE, Eperjesi F. Nutritional supplementation for type 2 diabetes: a systematic review. Ophthalmic and Physiological Optics 2008; 28: 503-23.
-
(2008)
Ophthalmic and Physiological Optics
, vol.28
, pp. 503-523
-
-
Bartlett, H.E.1
Eperjesi, F.2
-
193
-
-
33644807156
-
High-dose oral vitamin C partially replenishes vitamin C levels in patients with Type 2 diabetes and low vitamin C levels but does not improve endothelial dysfunction or insulin resistance
-
Chen H, Karne RJ, Hall G, et al. High-dose oral vitamin C partially replenishes vitamin C levels in patients with Type 2 diabetes and low vitamin C levels but does not improve endothelial dysfunction or insulin resistance. American J Physiology - Heart and Circulatory Physiology 2006; 290: H137-45.
-
(2006)
American J Physiology - Heart and Circulatory Physiology
, vol.290
-
-
Chen, H.1
Karne, R.J.2
Hall, G.3
-
194
-
-
34948814624
-
The relationship between dose of vitamin E and suppression of oxidative stress in humans
-
Roberts LJ, 2nd, Oates JA, Linton MF, et al. The relationship between dose of vitamin E and suppression of oxidative stress in humans. Free Radical Biology & Medicine 2007; 43: 1388-93.
-
(2007)
Free Radical Biology & Medicine
, vol.43
, pp. 1388-1393
-
-
Roberts 2nd, L.J.1
Oates, J.A.2
Linton, M.F.3
-
195
-
-
34447128568
-
Meta-analysis of the effects of n-3 polyunsaturated fatty acids on haematological and thrombogenic factors in type 2 diabetes
-
Hartweg J, Farmer AJ, Holman RR, Neil HA. Meta-analysis of the effects of n-3 polyunsaturated fatty acids on haematological and thrombogenic factors in type 2 diabetes. Diabetologia 2007; 50: 250-8.
-
(2007)
Diabetologia
, vol.50
, pp. 250-258
-
-
Hartweg, J.1
Farmer, A.J.2
Holman, R.R.3
Neil, H.A.4
-
197
-
-
54949103935
-
Alpha-lipoic acid supplementation and diabetes
-
Singh U, Jialal I. Alpha-lipoic acid supplementation and diabetes. Nutrition Reviews 2008; 66: 646-57.
-
(2008)
Nutrition Reviews
, vol.66
, pp. 646-657
-
-
Singh, U.1
Jialal, I.2
-
200
-
-
7944231021
-
Nutraceutical resources for diabetes prevention-an update
-
McCarty MF. Nutraceutical resources for diabetes prevention-an update. Medical Hypotheses 2005; 64: 151-8.
-
(2005)
Medical Hypotheses
, vol.64
, pp. 151-158
-
-
McCarty, M.F.1
-
201
-
-
67949094377
-
Effects of long-term antioxidant supplementation and association of serum antioxidant concentrations with risk of metabolic syndrome in adults
-
Czernichow S, Vergnaud AC, Galan P, et al. Effects of long-term antioxidant supplementation and association of serum antioxidant concentrations with risk of metabolic syndrome in adults. American J Clinical Nutrition 2009; 90: 329-35.
-
(2009)
American J Clinical Nutrition
, vol.90
, pp. 329-335
-
-
Czernichow, S.1
Vergnaud, A.C.2
Galan, P.3
-
202
-
-
0034254961
-
Effects of vitamin E supplementation on F(2)-isoprostane and thromboxane biosynthesis in healthy cigarette smokers
-
Patrignani P, Panara MR, Tacconelli S, et al. Effects of vitamin E supplementation on F(2)-isoprostane and thromboxane biosynthesis in healthy cigarette smokers. Circulation 2000; 102: 539-45.
-
(2000)
Circulation
, vol.102
, pp. 539-545
-
-
Patrignani, P.1
Panara, M.R.2
Tacconelli, S.3
-
203
-
-
77954371707
-
Nutraceuticals in diabetes and metabolic syndrome
-
Davi G, Santilli F, Patrono C. Nutraceuticals in diabetes and metabolic syndrome. Cardiovasc Ther 2010; 28: 216-26.
-
(2010)
Cardiovasc Ther
, vol.28
, pp. 216-226
-
-
Davi, G.1
Santilli, F.2
Patrono, C.3
-
204
-
-
34547733397
-
Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidasemediated oxidative/nitrosative stress
-
Sautin YY, Nakagawa T, Zharikov S, Johnson RJ. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidasemediated oxidative/nitrosative stress. American J Physiology - Cell Physiology 2007; 293: C584-C596.
-
(2007)
American J Physiology - Cell Physiology
, vol.293
-
-
Sautin, Y.Y.1
Nakagawa, T.2
Zharikov, S.3
Johnson, R.J.4
-
205
-
-
34547733397
-
Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidasemediated oxidative/nitrosative stress
-
Sautin YY, Nakagawa T, Zharikov S, Johnson RJ. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidasemediated oxidative/nitrosative stress. American J Physiology - Cell Physiology 2007; 293: C584-96.
-
(2007)
American J Physiology - Cell Physiology
, vol.293
-
-
Sautin, Y.Y.1
Nakagawa, T.2
Zharikov, S.3
Johnson, R.J.4
-
209
-
-
33947579534
-
Nutrigenomics-2006 update
-
Kaput J. Nutrigenomics-2006 update. Clinical Chem Laboratory Med 2007; 45: 279-87.
-
(2007)
Clinical Chem Laboratory Med
, vol.45
, pp. 279-287
-
-
Kaput, J.1
-
210
-
-
33846990448
-
Application of nutrigenomic concepts to Type 2 diabetes mellitus
-
Kaput J, Noble J, Hatipoglu B, Kohrs K, Dawson K, Bartholomew A. Application of nutrigenomic concepts to Type 2 diabetes mellitus. Nutrition, Metabolism and Cardiovascular Diseases 2007; 17: 89-103.
-
(2007)
Nutrition, Metabolism and Cardiovascular Diseases
, vol.17
, pp. 89-103
-
-
Kaput, J.1
Noble, J.2
Hatipoglu, B.3
Kohrs, K.4
Dawson, K.5
Bartholomew, A.6
-
211
-
-
33750431077
-
Metabolomics as a functional genomic tool for understanding lipid dysfunction in diabetes, obesity and related disorders
-
Griffin JL, Nicholls AW. Metabolomics as a functional genomic tool for understanding lipid dysfunction in diabetes, obesity and related disorders. Pharmacogenomics 2006; 7: 1095-107.
-
(2006)
Pharmacogenomics
, vol.7
, pp. 1095-1107
-
-
Griffin, J.L.1
Nicholls, A.W.2
-
212
-
-
0041326831
-
Effects of age and caloric restriction on glutathione redox state in mice
-
Rebrin I, Kamzalov S, Sohal RS. Effects of age and caloric restriction on glutathione redox state in mice. Free Radical Biology & Medicine 2003; 35: 626-35.
-
(2003)
Free Radical Biology & Medicine
, vol.35
, pp. 626-635
-
-
Rebrin, I.1
Kamzalov, S.2
Sohal, R.S.3
-
213
-
-
1642587081
-
A reduction in dietary saturated fat decreases body fat content in overweight, hypercholesterolemic males
-
Fernandez de la Puebla RA, Fuentes F, Perez-Martinez P, et al. A reduction in dietary saturated fat decreases body fat content in overweight, hypercholesterolemic males. Nutrition, Metabolism and Cardiovascular Diseases 2003; 13: 273-7.
-
(2003)
Nutrition, Metabolism and Cardiovascular Diseases
, vol.13
, pp. 273-277
-
-
Fernandez de la Puebla, R.A.1
Fuentes, F.2
Perez-Martinez, P.3
-
214
-
-
0033954443
-
High carbohydrate diets, triglyceride-rich lipoproteins, and coronary heart disease risk
-
Abbasi F, McLaughlin T, Lamendola C, et al. High carbohydrate diets, triglyceride-rich lipoproteins, and coronary heart disease risk. American J Cardiology 2000; 85: 45-8.
-
(2000)
American J Cardiology
, vol.85
, pp. 45-48
-
-
Abbasi, F.1
McLaughlin, T.2
Lamendola, C.3
-
215
-
-
20444389800
-
Antioxidant effect of virgin olive oil in patients with stable coronary heart disease: A randomized, crossover, controlled, clinical trial
-
Fito M, Cladellas M, de la Torre R, et al. Antioxidant effect of virgin olive oil in patients with stable coronary heart disease: a randomized, crossover, controlled, clinical trial. Atherosclerosis 2005; 181: 149-58.
-
(2005)
Atherosclerosis
, vol.181
, pp. 149-158
-
-
Fito, M.1
Cladellas, M.2
de la Torre, R.3
-
216
-
-
33847378451
-
Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: Systematic review and metaanalysis
-
Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and metaanalysis. JAMA 2007; 297: 842-57.
-
(2007)
JAMA
, vol.297
, pp. 842-857
-
-
Bjelakovic, G.1
Nikolova, D.2
Gluud, L.L.3
Simonetti, R.G.4
Gluud, C.5
-
217
-
-
2442421194
-
Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited
-
Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arteriosclerosis Thrombosis and Vascular Biology 2004; 24: 816-23.
-
(2004)
Arteriosclerosis Thrombosis and Vascular Biology
, vol.24
, pp. 816-823
-
-
Ceriello, A.1
Motz, E.2
-
218
-
-
0030048496
-
Oxidative stress and diabetic vascular complications
-
Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996; 19: 257-67.
-
(1996)
Diabetes Care
, vol.19
, pp. 257-267
-
-
Giugliano, D.1
Ceriello, A.2
Paolisso, G.3
-
219
-
-
59349121851
-
The therapeutic modulation of atherogenic dyslipidemia and inflammatory markers in the metabolic syndrome: What is the clinical relevance?
-
Rizzo M, Rizvi AA, Rini GB, Berneis K. The therapeutic modulation of atherogenic dyslipidemia and inflammatory markers in the metabolic syndrome: what is the clinical relevance? Acta Diabetologica 2009; 46: 1-11.
-
(2009)
Acta Diabetologica
, vol.46
, pp. 1-11
-
-
Rizzo, M.1
Rizvi, A.A.2
Rini, G.B.3
Berneis, K.4
-
220
-
-
34447135689
-
Metaanalysis of the effects of n-3 polyunsaturated fatty acids on lipoproteins and other emerging lipid cardiovascular risk markers in patients with type 2 diabetes
-
Hartweg J, Farmer AJ, Perera R, Holman RR, Neil HA. Metaanalysis of the effects of n-3 polyunsaturated fatty acids on lipoproteins and other emerging lipid cardiovascular risk markers in patients with type 2 diabetes. Diabetologia 2007; 50: 1593-602.
-
(2007)
Diabetologia
, vol.50
, pp. 1593-1602
-
-
Hartweg, J.1
Farmer, A.J.2
Perera, R.3
Holman, R.R.4
Neil, H.A.5
|